Mistras Group, Inc. (MG) Stock Price & Analysis
Mistras Group, Inc. (MG) closed at USD 21.42 on Thursday, October 22, 2026, up 0.52% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 21.31; the Oct 22, 2026 session ranged USD 21.1–21.52 on volume of 200,746 shares. Market capitalization is $682.45M, with a 52-week range of USD 9.45–21.92 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:25 UTC.
Also available as compact Markdown for AI agents: nexqual.com/MG.md
Key facts (MG)
- Last four reported quarters (through Jun 30, 2026): revenue $739M, net income $27.0M (3.6% margin), free cash flow $28.9M (SEC filings).
- Valuation: P/E 25.3x (avg 19.6x at the last 2 fiscal year-ends), EV/EBITDA 11.7x, net debt $150M.
- 1 of 80 tracked superinvestors hold MG (13F, Q2 2026): 0 new, 1 added, 0 reduced, 0 unchanged.
- Analysts: Buy (mean 2.00 on a 1–5 scale) (1 analysts), mean target USD 23 (range 22–24).
- Total return with dividends: 1Y +115.9% vs S&P 500 +14.9%; 5Y +123.1% vs S&P 500 +80.3%.
- Next earnings: 2026-11-04, EPS estimate USD 0.38, revenue estimate $202M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (MG)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $677M | $687M | $705M | $730M | $724M | $739M |
| Gross profit | $197M | $198M | $184M | $192M | $205M | — |
| Operating income | $18.2M | $19.8M | -$1.9M | $39.8M | $40.6M | $50.8M |
| Net income | $3.9M | $6.5M | -$17.5M | $19.0M | $16.8M | $27.0M |
| EPS (diluted) | $0.13 | $0.21 | -$0.58 | $0.60 | $0.53 | — |
| Free cash flow | $24.1M | $13.8M | $5.9M | $32.2M | $8.3M | $28.9M |
| Gross margin | 29.1% | 28.8% | 26.1% | 26.3% | 28.2% | — |
| Operating margin | 2.7% | 2.9% | -0.3% | 5.5% | 5.6% | 6.9% |
| Net margin | 0.6% | 0.9% | -2.5% | 2.6% | 2.3% | 3.6% |
| Revenue growth | +14.3% | +1.5% | +2.6% | +3.4% | -0.8% | — |
| Cash + short-term investments | $24.1M | $20.5M | $17.6M | $18.3M | $28.0M | — |
| Total debt | $203M | $191M | $190M | $170M | $178M | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (MG)
P/E 25.3x · P/S 0.9x · EV/EBITDA 11.7x · EV/Sales 1.1x · P/FCF 23.6x · P/B 2.8x · FCF yield 4.24% · Earnings yield 3.95% · Net debt $150M · EV $833M
P/E at fiscal year-ends: Dec 2025 24.1x, Dec 2024 15.1x.
Superinvestors (SEC 13F-HR, Q2 2026) (MG)
1 of 80 tracked investors hold MG. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| First Eagle Investment | First Eagle Investment Management | 0.02% | $9.7M | Added +96.7% |
Analysts (MG)
Consensus Buy (mean 2.00 on a 1–5 scale), 1 analysts; mean target USD 23 (low 22, high 24).
Total return (dividends reinvested) (MG)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +115.9% | +123.1% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +116.5% | +17.4% |
| Volatility (annualized) | 44.2% | 42.2% |
| Max drawdown | -22.2% (May 2026→Jul 2026) | -60.3% (Oct 2021→Nov 2022) |
MG analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.38 | $0.43 | -12.8% | $202.1M | 2 |
| Next quarter (ends Dec 2026) | $0.29 | $0.28 | +1.8% | $182.9M | 2 |
| Current fiscal year (ends Dec 2026) | $1.02 | $1.04 | -1.9% | $747.1M | 2 |
| Next fiscal year (ends Dec 2027) | $1.26 | $1.25 | +1.6% | $787.2M | 2 |
Key Statistics (as of October 23, 2026 at 09:25 UTC)
| Price | USD 21.42 |
|---|---|
| Change | ▲ 0.52% (up) |
| Previous Close | USD 21.31 |
| Open | USD 21.4 |
| Day Range | USD 21.1 – 21.52 |
| 52-Week Range | USD 9.45 – 21.92 |
| Volume | 200,746 shares |
| Market Cap | $682.45M |
| Exchange | NYQ |
Technical Analysis (MG)
Nexqual's technical model rates MG "STRONG BUY" based on 5 bullish and 0 bearish signals across 127 daily candles, as of October 23, 2026 at 09:25 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 62.67 (neutral) |
| vs SMA50 | Above (USD 20.06) |
| MACD | 0.38 (positive) |
Analyst Ratings (MG)
Wall Street analysts rate MG "Buy" based on 1 analysts, with a mean price target of USD 23 (range USD 22–24), per Nexqual as of October 23, 2026 at 09:25 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 23 |
| High Target | USD 24 |
| Low Target | USD 22 |
| Buy / Hold / Sell | 1 / 0 / 0 |
Earnings (MG)
| Next Earnings Date | 2026-11-04 |
|---|---|
| EPS Estimate | USD 0.38 |
| Revenue Estimate | $202.06M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.28 vs est 0.25 ▲ beat |
| 2026-03-31 | USD 0.08 vs est 0 ▲ beat |
| 2025-12-31 | USD 0.25 vs est 0.24 ▲ beat |
| 2025-09-30 | USD 0.46 vs est 0.29 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Financials & Fundamentals (MG)
| Total Revenue | $739.17M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +4.20% |
| Gross Margin | +31.56% |
| Operating Margin | +7.73% |
| Profit Margin | +3.65% |
| ROE | +11.78% |
| Debt / Equity | 1.02 |
| Current Ratio | 1.71 |
| Total Cash | $21.99M |
| Total Debt | $245.19M |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $28.92M (3.9% of revenue) |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Financial Health Score (MG)
Nexqual rates Mistras Group, Inc.'s overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 09:25 UTC.
| Growth | Weak — Revenue -1% YoY (annual), declining |
|---|---|
| Profitability | Solid — Gross margin 32%, operating 8% (last 12 months) |
| Balance Sheet | Mixed — $22M cash and investments vs $172M debt (Jun 2026, SEC) |
| Cash Flow | Mixed — FCF $29M (last 4 quarters to Jun 2026, SEC), slim 3.9% margin |
| Efficiency | Mixed — ROE 12%, ROA 6.3% |
Ownership (MG)
| Insider Ownership | +34.38% |
|---|---|
| Institutional Ownership | +65.64% |
| Shares Outstanding | 31.86M |
| Float | 13.43M |
| Short % of Float | +7.52% |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Leadership (MG)
Mistras Group, Inc. is led by Natalia Shuman, CEO, President & Director, per Nexqual as of October 23, 2026 at 09:25 UTC.
| CEO, President & Director | Natalia Shuman |
|---|---|
| Executive Chairman of the Board | Manuel N. Stamatakis |
| Senior Executive VP & CFO | Edward J. Prajzner |
| Executive VP & COO | Hani Hammad |
| Senior VP & Chief Marketing Officer | Theresa Feraren |
Major Backers & Investors (MG)
Notable institutional backers of Mistras Group, Inc. include Mill Road Capital Management Llc, Royce & Associates LP, Weber Capital Management LLC /ADV, according to Nexqual as of October 23, 2026 at 09:25 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Mill Road Capital Management Llc | 6.06% |
| Royce & Associates LP | 4.96% |
| Weber Capital Management LLC /ADV | 4.27% |
| Ies Holdings, Inc. | 3.53% |
| Federated Hermes, Inc. | 2.06% |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Small Cap Value Portfolio | 1.96% |
| ROYCE FUND-Royce Small-Cap Opportunity Fund | 1.75% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Dimensional Fund Advisors | 5.34% |
| BlackRock | 3.66% |
| Vanguard Group | 3.3% |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| EVLV | Evolv Technologies Holdings, In | USD 4.59 | ▲ 3.85% |
| CIX | CompX International Inc. | USD 35.81 | ▲ 3.8% |
| NSSC | NAPCO Security Technologies, In | USD 38.6 | ▲ 3.65% |
| CXW | CoreCivic, Inc. | USD 29.33 | ▼ 0.64% |
| GEO | Geo Group Inc (The) REIT | USD 26.94 | ▼ 2.53% |
| BRC | Brady Corporation | USD 82.65 | ▲ 0.38% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:25 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt